SAFETY AND PHARMACOKINETICS OF MIFENTIDINE AFTER INCREASING ORAL DOSES IN HEALTHY-SUBJECTS

被引：1
作者：
IMBIMBO, BP
SEIBERLING, M
PEUCKERT, U
HOEXTER, G
MAIERLENZ, H
VIDI, A
DANIOTTI, S
机构：
[1] BOEHRINGER INGELHEIM,MILAN,ITALY
[2] INST CLIN PHARMACOL,FREIBURG,FED REP GER
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 35卷 / 06期
关键词：
D O I：
10.1007/BF00637606
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：673 / 676
页数：4
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF PHENIRAMINE (AVIL) AND METABOLITES IN HEALTHY-SUBJECTS AFTER ORAL AND INTRAVENOUS ADMINISTRATION
    WITTE, PU
    IRMISCH, R
    HAJDU, P
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1985, 23 (01) : 59 - 62
  • [22] Pharmacokinetics and safety of sitafloxacin after single oral doses in healthy volunteers
    Wu, Guolan
    Wu, Lihua
    Hu, Xingjiang
    Zhou, Huili
    Liu, Jian
    Zhu, Meixiang
    Zheng, Yunliang
    Zhai, You
    Shentu, Jianzhong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (12) : 1037 - 1044
  • [23] ENPROFYLLINE KINETICS IN HEALTHY-SUBJECTS AFTER SINGLE DOSES
    BORGA, O
    ANDERSSON, KE
    EDHOLM, LE
    FAGERSTROM, PO
    LUNELL, E
    PERSSON, CG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (06) : 799 - 804
  • [24] SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE IN HEALTHY-SUBJECTS AFTER SINGLE AND REPEATED ORAL DOSES
    ALAHURULA, V
    MYLLYLA, VV
    ARVELA, P
    KARKI, NT
    HOKKANEN, E
    UPSALA JOURNAL OF MEDICAL SCIENCES, 1980, : 7 - 9
  • [25] PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS IN HEALTHY-SUBJECTS FOLLOWING SINGLE AND MULTIPLE DOSES
    FOSTER, RT
    JAMALI, F
    RUSSELL, AS
    ALBALLA, SR
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (01) : 70 - 73
  • [26] Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects
    Kroesser, S.
    Tillner, J.
    Fluck, M.
    Ungethuem, W.
    Wolna, P.
    Kovar, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (05) : 271 - 280
  • [27] PHARMACOKINETICS AND BIOAVAILABILITY OF OMEPRAZOLE AFTER SINGLE AND REPEATED ORAL-ADMINISTRATION IN HEALTHY-SUBJECTS
    ANDERSSON, T
    ANDREN, K
    CEDERBERG, C
    LAGERSTROM, PO
    LUNDBORG, P
    SKANBERG, I
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (05) : 557 - 563
  • [28] Safety, Tolerability, and Pharmacokinetics of Single Escalating Doses of Oral Semaglutide in Healthy Male Subjects
    Baekdal, Tine A.
    Blicher, Thalia M.
    Donsmark, Morten
    Sondergaard, Flemming L.
    DIABETES, 2017, 66 : A318 - A318
  • [29] PHARMACOKINETICS OF NADOLOL IN HEALTHY-SUBJECTS
    SCHAFERKORTING, M
    BACH, N
    KNAUF, H
    MUTSCHLER, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (01) : 125 - 127
  • [30] SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF FALDAPREVIR AFTER SINGLE RISING DOSES IN HEALTHY SUBJECTS
    Sennewald, R.
    Narjes, H.
    Yong, C.
    Nehmiz, G.
    Huang, F.
    Stern, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S69 - S69
12345